003000 — Bukwang Pharm Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Bukwang Pharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	3,787	-1,033	-39,569	-2,970	6,386
Depreciation
Amortisation
Non-Cash Items	7,676	8,159	490	5,643	9,380
Unusual Items
Purchased R&D
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	10,219	4,219	25,425	27,582	209
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	26,525	16,461	-9,362	34,362	21,464
Capital Expenditures	-790	-4,990	-2,835	-2,612	-11,194
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	5,539	1,839	516	-25,115	-84,488
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	4,749	-3,151	-2,319	-27,727	-95,682
Financing Cash Flow Items	-291	-3,218	-1,139	-67,286	-2,981
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-27,485	-10,398	76,839	-67,651	79,784
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	3,486	2,740	65,710	-61,136	6,117